| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Advances in Brief |
B Activity through Suppression of IKK Activity and I
B Degradation, Independent of Akt Activation1
Department of Molecular and Cellular Oncology, Breast Cancer Basic Research Program, The University of Texas M. D. Anderson Cancer Center, Houston, Texas 77030
Activation of the transcription factor nuclear factor
B (NF-
B) has been implicated in the protection of cells from apoptosis. We have shown previously that the adenovirus type 5 E1A sensitizes cells to radiation-induced apoptosis by inhibiting NF-
B activity. However, the exact mechanism of inhibition is not known. In this study, we compared the activity of inhibitor of nuclear factor-
B (I
B) kinase (IKK) and the degradation of I
B
in E1A transfectants and parental human cancer cells after ionizing radiation treatment. We found that radiation-induced IKK activity and I
B
degradation were inhibited in the E1A transfectants. Recently, Akt has been implicated in NF-
B activation. To test whether Akt is regulated by E1A and is involved in radiation-induced NF-
B activity, we examined the phosphorylation status of Akt in the E1A transfectants and parental cells and in irradiated cells. The results indicated that radiation induced Akt phosphorylation and that E1A inhibited basal but not radiation-induced Akt phosphorylation. We additionally examined radiation-induced NF-
B activity in cells stably transfected with a dominant-negative, inactive Akt and in parental cancer cells treated with a phosphatidylinositol 3-kinase inhibitor, wortmannin. We found that dominant-negative Akt and wortmannin did not block radiation-induced NF-
B activity. Thus, our results suggest that inhibition of IKK activity and I
B degradation is the predominant mechanism for E1A-mediated inhibition of radiation-induced NF-
B activity and that radiation-induced Akt activation cannot be inhibited by E1A and is likely independent of radiation-induced NF-
B activity.
This article has been cited by other articles:
![]() |
K-M Rau, H-Y Kang, T-L Cha, S A Miller, and M-C Hung The mechanisms and managements of hormone-therapy resistance in breast and prostate cancers Endocr. Relat. Cancer, September 1, 2005; 12(3): 511 - 532. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Shao, D.-F. Lee, Y. Wen, Y. Ding, W. Xia, B. Ping, H. Yagita, B. Spohn, and M.-C. Hung E1A Sensitizes Cancer Cells to TRAIL-Induced Apoptosis through Enhancement of Caspase Activation Mol. Cancer Res., April 1, 2005; 3(4): 219 - 226. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. L. Lee, H. S. Lee, J. Jung, S. J. Cho, H.-Y. Chung, W. H. Kim, Y.-W. Jin, C. S. Kim, and S. Y. Nam Nuclear Factor-{kappa}B Activation Correlates with Better Prognosis and Akt Activation in Human Gastric Cancer Clin. Cancer Res., April 1, 2005; 11(7): 2518 - 2525. [Abstract] [Full Text] [PDF] |
||||
![]() |
W.-P. Lee, D.-I. Tai, S.-L. Tsai, C.-T. Yeh, Y. Chao, S.-D. Lee, and M.-C. Hung Adenovirus Type 5 E1A Sensitizes Hepatocellular Carcinoma Cells to Gemcitabine Cancer Res., October 1, 2003; 63(19): 6229 - 6236. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. S. Russell and P. J. Tofilon Radiation-induced Activation of Nuclear Factor-kappa B Involves Selective Degradation of Plasma Membrane-associated Ikappa Balpha Mol. Biol. Cell, October 1, 2002; 13(10): 3431 - 3440. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. L. Cook, T. A. Walker, G. S. Worthen, and J. R. Radke Role of the E1A Rb-binding domain in repression of the NF-kappa B-dependent defense against tumor necrosis factor-alpha PNAS, July 23, 2002; 99(15): 9966 - 9971. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |